- VTRS +0.48%
Insider Sale: Chief Legal Officer Brian Roman Sells 89,419 Shares of Viatris Inc (VTRS)
Yahoo Finance · 2 weeks ago
Search results
Viatris is a global pharmaceutical company that believes in healthcare not as it is, but as it should be. Learn about our story, explore our products and browse career opportunities.
- 10.47Add to watchlist+0.05 (+0.48%)At close: Fri. Jun 7, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open10.42High10.60Low10.34
- Mkt Cap12.47BP/E (TTM)N/ADiv & Yield0.48 & 4.58%
- Prev. Close10.4252 Wk. Low8.7452 Wk. High13.62
What analysts are sayingTop storiesRelated stocks
Viatris is a unique global healthcare company focused on a wide variety of therapeutic areas, empowering people worldwide by expanding their access to a broad range of trusted, quality medications, regardless of geography or circumstance.
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
Find the latest Viatris Inc. (VTRS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Viatris produces high quality medicines across a broad range of therapeutic areas. Explore our brands, generics, biosimilars, over-the-counter products and API.
Viatris in the U.S. works to empower people worldwide to live healthier at every stage of life. Because of our unwavering belief that better access leads to better health, we leverage our best-in-class manufacturing and proven commercial capabilities to bring quality medicines to patients when and where they need them.
It’s a place where you can learn, grow and make an impact in the world. If you’re inspired by our bold mission to empower people worldwide to live healthier at every stage of life, explore global opportunities to join our team of dedicated individuals. Find your next role.
Viatris brings quality medicines to patients when and where they need them through our Global Healthcare Gateway. Learn about our mission and global impact and reach.
May 9, 2024 · Viatris Publishes Sustainability Report Showcasing 2022 Progress on Building Sustainable Access to Medicine. All Research and Reports.
Viatris harnesses the power of numerous branded drugs, including 20 iconic brands as well as several global key brands. Learn more about our branded products.
